Patients with inflammatory bowel disease (IBD) have a 48% greater relative risk of developing interstitial lung disease (ILD) ...

Abatacept is linked to lower mortality and fewer hospitalizations than rituximab in patients with rheumatoid ...

Persistent cough that lasts beyond two weeks should not be ignored. It can be signs of chronic bronchitis, tuberculosis, ...

The FDA approved Hernexeos for adults with unresectable or metastatic non-squamous non-small cell lung cancer.

Approval followed priority review and was based on response rates and duration of response demonstrated in the phase 1b ...

Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy ...

TX45 PH-ILD Phase 2 clinical trial is planned to initiate in 2026 to evaluate TX45’s safety and hemodynamic effects in subjects with Pulmonary Hypertension associated with Interstitial Lung Disease ...

Despite him and his wife's doubts, Blood gave GoFundMe a shot, creating a TikTok video inside the Mayo Clinic. It starred him and their kids sharing facts about the clinic and its history of ...

Rheumatoid arthritis (RA) commonly causes joint damage and fatigue, but it may sometimes cause symptoms that affect your skin ...

From alveolar injury to extracellular matrix accumulation, the complex biology of pulmonary fibrosis is being unraveled ...

Anti-Ro52 seropositivity is linked to increased rates of ILD progression and a decrease in progression-free and transplant-free survival.

A new AI tool helps predict survival in fibrotic lung disease, outperforming traditional clinical and imaging methods in a study of over 1,200 patients.